A pharmaceutical formulation comprising n-[2-(2,1,3-benzothiadiazol-5-ylamino)-6-(2,6-dichlorophenyl) pyrido[2,3-d]pyrimidin-7-yl]-n&rsquo-(1,1-dimethylethyl)-urea in the form of a base or a salt thereof
597963 Disclosed is a pharmaceutical formulation comprising N-[2-(2,1,3-benzothiadiazol-5-ylamino)-6-(2,6-dichlorophenyl) pyrido[2,3-d]pyrimidin-7-yl]-N&rsquo-(1,1-dimethylethyl)-urea (formula (I)), in the form of a base or in the form of a salt of an acid which is pharmaceutically acceptable, solubilized in a mixture of ethanol and of the surfactant macrogol 15 hydroxystearate in a surfactant/ethanol ratio by weight ranging from 25/75 to 80/20.
